We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

117 hedge funds and large institutions have $833M invested in Mirum Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 40 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

12,221% more call options, than puts

Call options by funds: $10.3M | Put options by funds: $84K

118% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 11

38% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 29

28% more capital invested

Capital invested by funds: $650M → $833M (+$183M)

13% more funds holding

Funds holding: 104 → 117 (+13)

0.95% more ownership

Funds ownership: 90.42% → 91.37% (+0.95%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

Holders
117
Holders Change
+13
Holders Change %
+12.5%
% of All Funds
1.86%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
24
Increased
40
Reduced
29
Closed
11
Calls
$10.3M
Puts
$84K
Net Calls
+$10.3M
Net Calls Change
+$9.98M

Top Buyers

Rank Fund Capital Flow
1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$18.3M
2
PA
Perceptive Advisors
New York
+$13.7M
3
CCM
Cadian Capital Management
New York
+$8.15M
4
PM
Prosight Management
Texas
+$5.9M
5
SCM
Soleus Capital Management
Connecticut
+$5.52M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$13.4M
2
BlackRock
BlackRock
New York
-$9.73M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$3.41M
4
Citigroup
Citigroup
New York
-$2.24M
5
SCM
Stonepine Capital Management
Oregon
-$2.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
RP
51
Repertoire Partners
New York
$1.2M +$1.14M +49,900 New
Jane Street
52
Jane Street
New York
$1.09M +$1.03M +45,295 New
Morgan Stanley
53
Morgan Stanley
New York
$1.06M -$767K -33,633 -43%
Swiss National Bank
54
Swiss National Bank
Switzerland
$1.05M -$98K -4,300 -9%
Janus Henderson Group
55
Janus Henderson Group
United Kingdom
$991K +$941K +41,284 New
Invesco
56
Invesco
Georgia
$975K -$8.43K -370 -0.9%
UBS Group
57
UBS Group
Switzerland
$974K -$1.52M -66,550 -62%
RJFSA
58
Raymond James Financial Services Advisors
Florida
$946K -$179K -7,853 -17%
SAM
59
Secure Asset Management
Michigan
$937K -$95K -4,167 -10%
Allspring Global Investments
60
Allspring Global Investments
North Carolina
$875K +$806K +35,347 +3,267%
Two Sigma Advisers
61
Two Sigma Advisers
New York
$728K -$1.13M -49,500 -62%
RJA
62
Raymond James & Associates
Florida
$687K +$201K +8,834 +45%
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$592K +$114 +5 +0%
AllianceBernstein
64
AllianceBernstein
Tennessee
$579K – – –
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$578K +$28.7K +1,261 +6%
UBS AM
66
UBS AM
Illinois
$549K +$61.2K +2,685 +13%
State of Wisconsin Investment Board
67
State of Wisconsin Investment Board
Wisconsin
$469K +$7.38K +324 +2%
Ameriprise
68
Ameriprise
Minnesota
$456K +$432K +18,965 New
GSEP
69
Golden State Equity Partners
California
$432K +$410K +17,980 New
Wells Fargo
70
Wells Fargo
California
$431K +$409K +17,925 New
Janney Montgomery Scott
71
Janney Montgomery Scott
Pennsylvania
$429K -$10.3K -450 -2%
VEA
72
Virtus ETF Advisers
New York
$410K +$6.82K +299 +2%
CS
73
Credit Suisse
Switzerland
$397K +$102K +4,495 +37%
PA
74
Profund Advisors
Maryland
$385K +$365K +16,009 New
Millennium Management
75
Millennium Management
New York
$369K +$350K +15,363 New
1 2
3
4 5

MIRM Hedge Fund Activity: Q1 2023 in Review

117 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q1 2023, worth a combined $833M — up 28% from $650M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new MIRM positions and 11 closed out — a net gain of 13 holders — while 40 added to existing stakes and 29 trimmed.

The largest buyer was Pictet Asset Management (Switzerland), opening a new position worth an estimated $18.3M. The largest seller was State Street, cutting an estimated $13.4M.

  • 117 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q1 2023, up from 104 in Q4 2022.
  • Funds reported $833M of Mirum Pharmaceuticals stock for Q1 2023, up 28% quarter-over-quarter.
  • 24 funds opened new Mirum Pharmaceuticals positions in Q1 2023 and 11 closed out, a net change of +13 holders.
  • The largest Mirum Pharmaceuticals buyer in Q1 2023 was Pictet Asset Management (Switzerland), an estimated $18.3M added.
  • The largest Mirum Pharmaceuticals seller in Q1 2023 was State Street, an estimated $13.4M sold.

Based on aggregated 13F filings for Q1 2023.